ATE180275T1 - Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin - Google Patents

Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin

Info

Publication number
ATE180275T1
ATE180275T1 AT92921384T AT92921384T ATE180275T1 AT E180275 T1 ATE180275 T1 AT E180275T1 AT 92921384 T AT92921384 T AT 92921384T AT 92921384 T AT92921384 T AT 92921384T AT E180275 T1 ATE180275 T1 AT E180275T1
Authority
AT
Austria
Prior art keywords
epimorphine
epimorphin
base sequence
gene
active substance
Prior art date
Application number
AT92921384T
Other languages
English (en)
Inventor
Yohei Hirai
Makoto Takashina
Kyoko Takebe
Original Assignee
Biomaterial Res Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomaterial Res Inst Co Ltd filed Critical Biomaterial Res Inst Co Ltd
Application granted granted Critical
Publication of ATE180275T1 publication Critical patent/ATE180275T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92921384T 1991-10-16 1992-10-15 Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin ATE180275T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29485791 1991-10-16
JP29485691 1991-10-16
JP12290692 1992-04-17
JP13569292 1992-04-30

Publications (1)

Publication Number Publication Date
ATE180275T1 true ATE180275T1 (de) 1999-06-15

Family

ID=27470892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921384T ATE180275T1 (de) 1991-10-16 1992-10-15 Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin

Country Status (7)

Country Link
US (1) US5726298A (de)
EP (1) EP0562123B1 (de)
JP (1) JP2849517B2 (de)
AT (1) ATE180275T1 (de)
CA (1) CA2098397C (de)
DE (1) DE69229219T2 (de)
WO (1) WO1993008213A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06293800A (ja) * 1992-10-15 1994-10-21 Bio Material Kenkyusho:Kk 新規生理活性物質エピモルフィン、それをコードする 遺伝子及びエピモルフィンに対する抗体
EP1624068A1 (de) * 1993-06-01 2006-02-08 Life Technologies Inc. Genetische Impfung mit kationischen Lipidstoffen
EP0698666B1 (de) 1994-06-21 2006-04-26 Sumitomo Electric Industries, Limited Modifiziertes Epimorphin
JPH107698A (ja) 1996-04-24 1998-01-13 Sumitomo Electric Ind Ltd エピモルフィン・アンタゴニスト
JP3903503B2 (ja) * 1996-11-18 2007-04-11 住友電気工業株式会社 可溶性ポリペプチド
JP2000060560A (ja) 1998-08-20 2000-02-29 Sumitomo Electric Ind Ltd 偶蹄目エピモルフィン
DE69937964T2 (de) * 1998-11-12 2009-01-02 Invitrogen Corp., Carlsbad Transportreagentien
US20050008602A1 (en) * 2000-06-05 2005-01-13 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
US7241731B2 (en) * 2000-06-05 2007-07-10 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
KR100791442B1 (ko) * 2000-06-05 2008-01-04 스미토모덴키고교가부시키가이샤 올리고펩티드
AU2002301607B2 (en) * 2001-11-13 2008-12-11 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
AU2003203527A1 (en) * 2002-04-12 2003-10-30 Sumitomo Electric Industries, Ltd. Control of the ratio of lap to lip
EP1626054A4 (de) 2003-05-16 2007-01-24 Sumitomo Electric Industries Oligopeptid
JP5228246B2 (ja) * 2007-11-05 2013-07-03 国立大学法人京都大学 三次元疾患皮膚再構築物
EP3169310A1 (de) 2014-07-15 2017-05-24 Life Technologies Corporation Zusammensetzungen mit lipidaggregaten und verfahren zur effizienten bereitstellung von molekülen an zellen

Also Published As

Publication number Publication date
JPH0625295A (ja) 1994-02-01
DE69229219T2 (de) 1999-11-04
JP2849517B2 (ja) 1999-01-20
EP0562123B1 (de) 1999-05-19
CA2098397C (en) 1999-07-06
EP0562123A4 (de) 1995-03-15
US5726298A (en) 1998-03-10
DE69229219D1 (de) 1999-06-24
CA2098397A1 (en) 1993-04-17
WO1993008213A1 (fr) 1993-04-29
EP0562123A1 (de) 1993-09-29

Similar Documents

Publication Publication Date Title
ATE180275T1 (de) Neuartige, physiologisch aktive substanz epimorphin, für sie kodierende gene und antikörper gegen epimorphin
Kim et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
Hebert et al. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding.
James Interactions between cytokines and α2-macroglobulin
Moon et al. Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation
Kornack et al. The generation, migration, and differentiation of olfactory neurons in the adult primate brain
Cheng et al. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
DE68929546T4 (de) Menschlicher Fc-gamma-Rezeptor III
US5416192A (en) Epithelins: novel cysteine-rich growth modulating proteins
AU2349697A (en) Monoclonal antibodies against the interferon receptor with neutralizing activity against type I interferon
DE68920693D1 (de) Gefriergetrocknete Zusammensetzung, die ein mit Meerrettichperoxydase markiertes Fab'-Fragment eines gegen menschliches Beta-Interferon gerichteten Antikörpers und Trehalose enthält; EIA Kit, der diese Zusammensetzung enthält.
Kadi et al. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro
FI921353A0 (fi) Inhibering av transformerande vaextfaktor b foer foerhindrande av ackumulation av extracellulaer matris.
JP2007209349A (ja) 新規な神経栄養因子
ES2161246T3 (es) Factor transformante de crecimiento alfa h1.
Diana et al. Co-localization of interleukin-1 receptor type I and interleukin-1 receptor antagonist with vasopressin in magnocellular neurons of the paraventricular and supraoptic nuclei of the rat hypothalamus
CN109535243B (zh) 人肝细胞生长因子突变体及其应用
Maldonado-Ruiz et al. MCP-1 signaling disrupts social behavior by modulating brain volumetric changes and microglia morphology
ES2259458T3 (es) Persefina humana.
ATE142256T1 (de) Polypeptid und dessen herstellung
CA2420226A1 (en) Methods for treating demyelinating diseases
Haagmans et al. Transforming growth factor beta production during rat cytomegalovirus infection.
DE69232779D1 (de) Menschlicher Rezeptor für das Follikel-stimulierendes Hormon.
Hampson et al. An RSPCA/FRAME survey of the use of non-human primates as laboratory animals in Great Britain, 1984–1988
Josephsen et al. The effect of a single dose of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on presecretory ameloblast differentiation in rat incisors.